abstract |
FIELD: medicine; pharmaceuticals.SUBSTANCE: invention refers to pharmaceutical industry and represents a therapeutic agent for treating detrusor hyperactivity with impaired contractility, containing 3-(15-hydroxypentadecyl)-2,4,4-trimethyl-2-cyclohexen-1-one, its pharmaceutically acceptable salt or solvate thereof.EFFECT: invention provides extending the range of products for treating detrusor hyperactivity with impaired contractility.5 cl, 3 dwg, 2 tbl, 2 ex |